CClinicalTrials.gg
CompletedNCT03557710Updated Aug 14, 2023

Devaluing Foods to Change Eating Behavior

An interventional study of Devaluing energy-dense foods for cancer-control in Overweight and Obesity and Cancer, sponsored by University of Oregon. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-14.

Sponsored by University of Oregon · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
253
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Excessive eating of energy-dense foods and obesity are risk factors for a range of cancers. There are programs to reduce intake of these foods and weight loss, but the effects of the programs rarely last. This project tests whether altering the value of cancer-risk foods can create lasting change, and uses neuroimaging to compare the efficacy of two programs to engage the valuation system on a neural level. Results will establish the pathways through which the programs work and suggest specific treatments for individuals based on a personalized profile.

Read the detailed description

Obesity and intake of certain foods increase cancer risk, but the most common treatment (behavioral weight loss programs) rarely produces lasting weight loss and eating behavior change, apparently because caloric restriction increases the reward value of food and prompts energy-sparing adaptations. Interventions that reduce the implicit valuation of cancer-risk foods (e.g., red meats, refined sugar) may be more effective. Emerging data suggest that behavioral response training and cognitive reappraisal training reduce valuation of such foods, which leads to decrease intake of these foods and weight loss. Internalized incentive value is reflected in a ventromedial prefrontal cortex (vmPFC) / orbitofrontal cortex valuation system, which encodes the implicit reward value of food and is central to a reinforcement cycle that perpetuates unhealthy eating. Thus, the vmPFC valuation system is a promising target for intervention because changes to the system might disrupt the unhealthy reinforcement cycle. Interestingly, various interventions influence the vmPFC through distinct pathways. Behavioral training alters motor input to valuation regions, whereas cognitive training relies on lateral prefrontal "top-down" regions. The proposed translational neuroscience experiment will compare the efficacy with which two novel treatments cause lasting change in food valuation, and whether a composite of theory-based baseline individual differences in relevant processes (such as response tendencies and cognitive styles) moderate treatment effects. We will randomize 300 overweight/obese adults who are at risk for eating- and obesity-related cancers to behavioral response training toward healthy foods and away from cancer-risk foods, a cognitive reappraisal intervention focused on cancer-risk foods, or non-food inhibitory control training. Aim 1 compares the efficacy and mechanisms of action of these two interventions to reduce valuation of cancer-risk foods relative to the active control condition, using neural, behavioral, self-report, and physiological measures of the process and outcomes. Aim 2 is to establish the temporal pattern and durability of the effects across time; food intake and habits, body fat, BMI, and waist-to-hip ratio will be measured pre, post, and at 3-, 6-, and 12-month follow-up. Aim 3 uses machine learning to build and validate a low-cost, easy-to-administer composite that predicts whether and for how long an individual is likely to respond to intervention, and to which treatment. We hypothesize that self-report measures specifically related to valuation (e.g., willingness-to-pay) and to intervention-specific pathways to valuation (e.g., behavioral response tendencies, cognitive style) will predict differential response. Discovering these individual differences will provide a practical, low-cost tool to help interventionists "match" a given person to an effective treatment for that person. This project is very innovative because no study has directly compared the distinct and common effects of these treatments on valuation, used brain imaging to study the mechanism of effects, tested whether these interventions produce a lasting change in food valuation and body fat, or built and validated a composite that moderates response.

02

Conditions studied

  • Overweight and Obesity
  • Cancer

Browse trials for

Keywords

  • eating
  • overweight
  • obesity
  • cancer risk
  • translational neuroscience
  • cognitive reappraisal
  • functional magnetic resonance imaging (fMRI)
  • vmPFC
  • inhibitory control
  • valuation
03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.

This study's enrollment of 253 is above the median of 73 across 3,175 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

University of Oregon is the lead sponsor of 75 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • overweight to obese range (BMI 25-35)

Exclusion criteria

Exclusion Criteria:

  • metal implants (e.g., braces, permanent retainers, pins)
  • metal fragments, pacemakers or other electronic medical implants
  • claustrophobia
  • weight ˃ 550 lbs.
  • Women who are pregnant or believe they might be pregnant
  • people who have been diagnosed with past or current medical, psychiatric, neurological, eating disorders, or are taking psychotropic medications
  • urine screen to exclude participants who are acutely intoxicated
  • screen for handedness

Beyond these criteria, participants will be recruited without exclusions based on gender, race, or ethnicity, so our sample will reflect the diversity in the local population (Lane County, Oregon) with regard to gender, race, and ethnicity.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
253 participants (actual)

Study arms

  • Experimental
    Behavioral Response Training

    In Arm 1 of Devaluing energy-dense foods for cancer-control, participants will complete computer delivered versions of the stop-signal, go/no-go, and dot-probe training tasks in 8 30-min biweekly visits to the lab, with breaks between training blocks in which participants sit with their eyes closed to allow consolidation of learning. Participants will also complete a weekly 15-min training task online from home. Total training time = 345 min. Training will involve 100 images of cancer risk foods that participants regularly eat, including red and processed meats; high-sugar foods; heavily salted, smoked, and pickled foods; fries, chips, and snacks with trans-fats, and 100 images of healthy foods that participants rate as palatable, including vegetables, fruits, nuts, and whole grains.

    Behavioral: Devaluing energy-dense foods for cancer-control

  • Experimental
    Cognitive Reappraisal Training

    Arm 2 of the Devaluing energy-dense foods for cancer-control intervention will be delivered via computer-assisted in-person training. Between baseline and endpoint sessions, participants will practice reappraisal on a computer, under close supervision of a facilitator, in 8 30-min twice-weekly individual sessions. During sessions, participants will practice cognitive reappraisal to reduce the value of cancer risk foods. Participants will also practice reappraisal of cancer risk foods on a computer at home, twice weekly for 15 minutes, for a total intervention time of contact of 345 minutes. The facilitator will review homework completed by participants and offer corrective feedback. The home practice is intended to promote generalization of use of this skill in the natural environment.

    Behavioral: Devaluing energy-dense foods for cancer-control

  • Active comparator
    Generic Response Training

    In Arm 3 (active control) of the Devaluing energy-dense foods for cancer-control intervention will be identical in duration and contact time to the behavioral response training described above (345 min total), but will involve nonfood images (birds and flowers), as described in the pilot trial. Participants will be informed that this intervention is designed to improve response inhibition, which should lead to eating change and weight loss given that impulsivity increases the risk for overeating, ensuring the credibility of the control arm.

    Behavioral: Devaluing energy-dense foods for cancer-control

Interventions

  • BehavioralDevaluing energy-dense foods for cancer-control

    A 3-arm randomized controlled trial experiment study over 12 months. At baseline, participants will complete behavioral, neural, and self-report measures related to food, specifically measures of food valuation and of the proximal neural systems hypothesized to be linked to each of the 2 experimental arms. We will also measure food intake and body composition at baseline. Then participants will be randomized to one of 3 arms (2 experimental + 1 active control) for 8 30-min sessions to occur twice weekly at the University of Oregon for 30 days. At endpoint (\~1 month following baseline), all behavioral, neural, and self-report measures will be reassessed, as will eating, habit, and body composition measures. Follow-ups at 3, 6, and 12 months will assess all measures except neuroimaging.

    Also known as: Devaluing foods to change eating behavior

06

What researchers measure

Primary outcomes

  1. Change from Baseline Food Intake at 1 month using dietary assessment tool

    Assessed with the Automated Self-Administered 24-Hour (ASA24) Dietary Assessment Tool The National Cancer Institutes's standard self-assessment instrument to comprehensively measure food intake.

    Time frame: baseline, 1 month

  2. Change from Baseline Food Intake at 1 month, Self-Report Questionnaire

    Food-Frequency Questionnaire modified to include cancer risk foods

    Time frame: baseline, 1 month

Secondary outcomes

  1. Change from Baseline Body Fat Percent at 1 month

    Assessed with a BodPod (body pod) air displacement system

    Time frame: baseline, 1 month

  2. Change from Baseline Body Mass Index at 1 month

    Index of body composition based on height and weight

    Time frame: baseline, 1 month

  3. Change from Baseline Waist-to-Hip Ratio at 1 month

    Index of body morphology based on external measurements

    Time frame: baseline, 1 month

  4. Change from Baseline Food Approach and Avoidance Behavior at 1 month, Self-Report Questionnaire 2

    Barratt Impulsivity self-report questionnaire, measuring the construct of impulsivity. There are three subscales: Attentional impulsivity (8 items), motor impulsivity (10 items) non-planning impulsivity (12 items). Participants respond to each item on a 1-to-4 Likert scale and scores are averaged within subscales (yielding three 1-to-4 average scores) then averaged across the three subscales to yield one 1-to-4 overall score. Higher scores indicate higher impulsivity, which is a worse outcome.

    Time frame: baseline, 1 month

  5. Change from Baseline Food Approach and Avoidance Behavior at 1 month, Self-Report Questionnaire 3

    Restraint Scale self-report questionnaire. This questionnaire measures the construct of dietary restraint. There are 2 subscales: concern for dieting and weight fluctuations. Participants answer 6 questions about concern for dieting (1-to-5) that are averaged to create a 1-to-5 score on dieting concern. Dieting concern is expected to be u-shaped in terms of better or worse, where no concern or extreme concern is worse and moderate concern is better. Participants answer 4 questions about weight fluctuations (1-to-5) that are averaged to create a 1-to-5 score for weight fluctuation. Great fluctuation is a worse outcome.

    Time frame: baseline, 1 month

  6. Change from Baseline Cognitive Tendencies at 1 month, Self-Report Questionnaire 1

    Need for Cognition self-report questionnaire, which measures the construct of cognitive engagement and enjoyment of thinking. Participants complete 18 items on a 9-point Likert scale (-4 to +4) and scores are averaged across all items to create a single score that ranges from -4 to +4. Higher scores indicate a better outcome, indicating more enjoyment of thinking processes.

    Time frame: baseline, 1 month

  7. Change from Baseline Cognitive Tendencies at 1 month, Self-Report Questionnaire 2

    Craving Regulation Scale self-report questionnaire, which measures the construct of self-regulation of food cravings. There are 24 items total, with 4 items within each of 6 subscales: avoidance of temptation, controlling temptations, distraction, suppression, goal/rule setting, and goal deliberation. Responses are on a 1-to-5 Likert scale and averaged within subscales to create 6 1-to-5 average ratings. Those six averages are also averaged to create an overall score. Greater scores indicate better self-regulation of craving, which is a desired outcome.

    Time frame: baseline, 1 month

  8. Change from Baseline Food-related Habitual Behavior at 1 month, Self-report Questionnaire 1

    Food version of the Self-Report Habit Index self-report questionnaire. This measures the construct of habitual eating of healthy and unhealthy foods. The scale contains two subscales: healthy foods and unhealthy foods. Each subscale contains 12 items, and responses are on a 1-to-5 Likert scale. Responses are averaged within each subscale to create 1-to-5 average ratings for habitual eating of healthy and unhealthy foods, respectively. The subscales are reported separately and not combined. Greater numbers indicate more habitual eating, so lower averages on the unhealthy subscale and higher averages on the healthy subscale indicate a better outcome.

    Time frame: baseline, 1 month

  9. Change from Baseline Cancer Risk and Healthy Food Craving and Valuation at 1 month, Self-report Questionnaire 2

    Food Craving Inventory self-report questionnaire measuring craving and valuation in dollars per serving of cancer risk and healthy foods. There are 28 items on each subscale (one for craving and one for valuation), and the items are averaged within each subscale. The range of the craving scale is 1-5 (i.e., average of 28 1-to-5 Likert ratings) and the range of the valuation scale is 1-4 (i.e., average of 28 1-to-4 Likert ratings). The subscales are reported separately and not combined. Greater numbers indicate more craving / value of the unhealthy foods, so lower numbers indicate a better outcome.

    Time frame: baseline, 1 month

  10. Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Behavioral marker, Task 1

    Performance on a standard inhibitory control task (Stop-Signal) with personal risk cues

    Time frame: baseline, 1 month

  11. Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Behavioral marker, Task 2

    Performance on a standard inhibitory control task (Go/No-Go) with personal risk cues

    Time frame: baseline, 1 month

  12. Change from Baseline Cognitive Reappraisal of Food at 1 month, Behavioral marker

    Performance on a Regulation of Craving Task for Food

    Time frame: baseline, 1 month

  13. Change from Baseline Valuation of Subjective Value of Various Foods at 1 month, Behavioral marker

    Performance on Willingness-to-Pay Task - Food

    Time frame: baseline, 1 month

  14. Change from Baseline Habitual Response to Food at 1 month, Behavioral marker

    Performance on Speeded Cue-Behavior Association Task

    Time frame: baseline, 1 month

  15. Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Neural marker, Task 1

    Premotor, basal ganglia, dorsal cingulate, and Thalamus Activity during standard inhibitory control task (Stop-Signal) with personal risk cues

    Time frame: baseline, 1 month

  16. Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Neural marker, Task 2

    Premotor, basal ganglia, dorsal cingulate, and Thalamus Activity during standard inhibitory control task (Go/No-Go) with personal risk cues

    Time frame: baseline, 1 month

  17. Change from Baseline Cognitive Reappraisal of Food at 1 month, Neural marker

    Dorsolateral Prefrontal Cortex and ventrolateral Prefrontal Cortex activity during Regulation of Craving Task for Food

    Time frame: baseline, 1 month

  18. Change from Baseline Habitual Response to Food at 1 month, Neural marker

    Shift from ventral to dorsal striatum activity during Speeded Cue-Behavior Association Task

    Time frame: baseline, 1 month

  19. Change from Baseline Valuation of Subjective Value of Various Foods at 1 month, Neural marker

    Ventromedial prefrontal cortex activity during the Willingness-to-Pay Task - Food

    Time frame: baseline, 1 month

07

Study locations

1 site
  • University of Oregon, Lewis Integrative Sciences Building
    Eugene, Oregon 97403, United States
08

References and documents

Publications

  • Berkman ET, Burklund L, Lieberman MD. Inhibitory spillover: intentional motor inhibition produces incidental limbic inhibition via right inferior frontal cortex. Neuroimage. 2009 Aug 15;47(2):705-12. doi: 10.1016/j.neuroimage.2009.04.084. Epub 2009 May 6. PubMed 19426813 ↗
  • Berkman ET, Falk EB. Beyond Brain Mapping: Using Neural Measures to Predict Real-World Outcomes. Curr Dir Psychol Sci. 2013 Feb;22(1):45-50. doi: 10.1177/0963721412469394. PubMed 24478540 ↗
  • Berkman ET, Falk EB, Lieberman MD. In the trenches of real-world self-control: neural correlates of breaking the link between craving and smoking. Psychol Sci. 2011 Apr;22(4):498-506. doi: 10.1177/0956797611400918. Epub 2011 Mar 4. PubMed 21378368 ↗
  • Berkman ET, Kahn LE, Merchant JS. Training-induced changes in inhibitory control network activity. J Neurosci. 2014 Jan 1;34(1):149-57. doi: 10.1523/JNEUROSCI.3564-13.2014. PubMed 24381276 ↗
  • Giuliani NR, Calcott RD, Berkman ET. Piece of cake. Cognitive reappraisal of food craving. Appetite. 2013 May;64:56-61. doi: 10.1016/j.appet.2012.12.020. Epub 2013 Jan 9. PubMed 23313699 ↗
  • Giuliani NR, Mann T, Tomiyama AJ, Berkman ET. Neural systems underlying the reappraisal of personally craved foods. J Cogn Neurosci. 2014 Jul;26(7):1390-402. doi: 10.1162/jocn_a_00563. Epub 2014 Jan 6. PubMed 24392892 ↗
  • Giuliani NR, Tomiyama AJ, Mann T, Berkman ET. Prediction of daily food intake as a function of measurement modality and restriction status. Psychosom Med. 2015 Jun;77(5):583-90. doi: 10.1097/PSY.0000000000000187. PubMed 25984820 ↗
  • Stice E, Burger K, Yokum S. Caloric deprivation increases responsivity of attention and reward brain regions to intake, anticipated intake, and images of palatable foods. Neuroimage. 2013 Feb 15;67:322-30. doi: 10.1016/j.neuroimage.2012.11.028. Epub 2012 Nov 28. PubMed 23201365 ↗
  • Stice E, Lawrence NS, Kemps E, Veling H. Training motor responses to food: A novel treatment for obesity targeting implicit processes. Clin Psychol Rev. 2016 Nov;49:16-27. doi: 10.1016/j.cpr.2016.06.005. Epub 2016 Jul 21. PubMed 27498406 ↗
  • Stice E, Marti CN, Spoor S, Presnell K, Shaw H. Dissonance and healthy weight eating disorder prevention programs: long-term effects from a randomized efficacy trial. J Consult Clin Psychol. 2008 Apr;76(2):329-40. doi: 10.1037/0022-006X.76.2.329. PubMed 18377128 ↗
  • Stice E, Presnell K, Gau J, Shaw H. Testing mediators of intervention effects in randomized controlled trials: An evaluation of two eating disorder prevention programs. J Consult Clin Psychol. 2007 Feb;75(1):20-32. doi: 10.1037/0022-006X.75.1.20. PubMed 17295560 ↗
  • Stice E, Rohde P, Durant S, Shaw H. A preliminary trial of a prototype Internet dissonance-based eating disorder prevention program for young women with body image concerns. J Consult Clin Psychol. 2012 Oct;80(5):907-16. doi: 10.1037/a0028016. Epub 2012 Apr 16. PubMed 22506791 ↗
  • Stice E, Rohde P, Gau J, Shaw H. An effectiveness trial of a dissonance-based eating disorder prevention program for high-risk adolescent girls. J Consult Clin Psychol. 2009 Oct;77(5):825-34. doi: 10.1037/a0016132. PubMed 19803563 ↗
  • Stice E, Rohde P, Shaw H, Gau J. An effectiveness trial of a selected dissonance-based eating disorder prevention program for female high school students: Long-term effects. J Consult Clin Psychol. 2011 Aug;79(4):500-8. doi: 10.1037/a0024351. PubMed 21707136 ↗
  • Stice E, Yokum S, Burger K, Rohde P, Shaw H, Gau JM. A pilot randomized trial of a cognitive reappraisal obesity prevention program. Physiol Behav. 2015 Jan;138:124-32. doi: 10.1016/j.physbeh.2014.10.022. Epub 2014 Oct 30. PubMed 25447334 ↗
  • Stice E, Yokum S, Veling H, Kemps E, Lawrence NS. Pilot test of a novel food response and attention training treatment for obesity: Brain imaging data suggest actions shape valuation. Behav Res Ther. 2017 Jul;94:60-70. doi: 10.1016/j.brat.2017.04.007. Epub 2017 Apr 19. PubMed 28505470 ↗
  • Fisher PA, Berkman ET. Designing Interventions Informed by Scientific Knowledge About Effects of Early Adversity: A Translational Neuroscience Agenda for Next Generation Addictions Research. Curr Addict Rep. 2015 Dec 1;2(4):347-353. doi: 10.1007/s40429-015-0071-x. Epub 2015 Sep 28. PubMed 26985399 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03557710
Lead sponsor
University of Oregon
Responsible party
Sponsor
First posted
Jun 15, 2018
Start date
May 1, 2018
Primary completion
May 1, 2023
Completion
Jun 30, 2023
Last update
Aug 14, 2023

Study contacts

Elliot Berkman, Ph.D.
principal investigator · University of Oregon

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion